EP1578944A4 - Zusammensetzungen und verfahren, um auf die abstammung zu schliessen - Google Patents

Zusammensetzungen und verfahren, um auf die abstammung zu schliessen

Info

Publication number
EP1578944A4
EP1578944A4 EP03788685A EP03788685A EP1578944A4 EP 1578944 A4 EP1578944 A4 EP 1578944A4 EP 03788685 A EP03788685 A EP 03788685A EP 03788685 A EP03788685 A EP 03788685A EP 1578944 A4 EP1578944 A4 EP 1578944A4
Authority
EP
European Patent Office
Prior art keywords
compositions
methods
inferring ancestry
ancestry
inferring
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP03788685A
Other languages
English (en)
French (fr)
Other versions
EP1578944A2 (de
Inventor
Tony N Frudakis
Mark D Shriver
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DNAPrint Genomics Inc
Original Assignee
DNAPrint Genomics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DNAPrint Genomics Inc filed Critical DNAPrint Genomics Inc
Publication of EP1578944A2 publication Critical patent/EP1578944A2/de
Publication of EP1578944A4 publication Critical patent/EP1578944A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B10/00—ICT specially adapted for evolutionary bioinformatics, e.g. phylogenetic tree construction or analysis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B45/00—ICT specially adapted for bioinformatics-related data visualisation, e.g. displaying of maps or networks

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Addiction (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Psychiatry (AREA)
  • Biophysics (AREA)
  • Diabetes (AREA)
  • Physiology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Obesity (AREA)
  • Evolutionary Biology (AREA)
  • Medical Informatics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Microbiology (AREA)
  • Psychology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Theoretical Computer Science (AREA)
EP03788685A 2002-08-19 2003-08-19 Zusammensetzungen und verfahren, um auf die abstammung zu schliessen Withdrawn EP1578944A4 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US40435702P 2002-08-19 2002-08-19
US404357P 2002-08-19
US46761303P 2003-05-02 2003-05-02
US467613P 2003-05-02
PCT/US2003/026229 WO2004016768A2 (en) 2002-08-19 2003-08-19 Compositions and methods for inferring ancestry

Publications (2)

Publication Number Publication Date
EP1578944A2 EP1578944A2 (de) 2005-09-28
EP1578944A4 true EP1578944A4 (de) 2009-12-23

Family

ID=31891429

Family Applications (1)

Application Number Title Priority Date Filing Date
EP03788685A Withdrawn EP1578944A4 (de) 2002-08-19 2003-08-19 Zusammensetzungen und verfahren, um auf die abstammung zu schliessen

Country Status (5)

Country Link
EP (1) EP1578944A4 (de)
JP (2) JP2006514553A (de)
AU (2) AU2003265572A1 (de)
CA (1) CA2496155A1 (de)
WO (1) WO2004016768A2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006214039A1 (en) * 2005-02-18 2006-08-24 Dna Print Genomics Multiplex assays for inferring Ancestry
FR2914316A1 (fr) * 2006-11-15 2008-10-03 Igna Inst Genetique Nantes Atl Methodes et outils pour determiner l'origine d'un sujet.
FR2910147B1 (fr) * 2006-12-19 2009-02-06 Galderma Res & Dev S N C Snc Methode correctrice de traitement de resultats d'experiences transcriptomiques obtenus par analyse differentielle
AU2013312355A1 (en) * 2012-09-06 2014-09-18 Ancestry.Com Dna, Llc Using haplotypes to infer ancestral origins for recently admixed individuals
US11341378B2 (en) 2016-02-26 2022-05-24 Nec Corporation Information processing apparatus, suspect information generation method and program
CN111061510B (zh) * 2019-12-12 2021-01-05 湖南毂梁微电子有限公司 一种可扩展的asip结构平台及指令处理方法
CN118028493B (zh) * 2024-04-11 2024-07-23 南方医科大学 包含73个多态性dip位点的复合扩增检测体系及其应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001077381A2 (en) * 2000-04-11 2001-10-18 Isis Innovation Limited Dna analysis for determination of ancestry

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7957907B2 (en) * 2001-03-30 2011-06-07 Sorenson Molecular Genealogy Foundation Method for molecular genealogical research
EP1873257A3 (de) * 2001-05-25 2008-03-19 DNAPrint Genomics, Inc. Zusammensetzung und Verfahren zur Ableitung von Pigmentationsmerkmalen

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001077381A2 (en) * 2000-04-11 2001-10-18 Isis Innovation Limited Dna analysis for determination of ancestry

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
COLLINS-SCHRAMM H E ET AL.: "Markers that discriminate between European and African ancestry show limited variation within Africa", HUMAN GENETICS, vol. 111, December 2002 (2002-12-01), pages 566 - 569, XP002553829 *
DATABASE EMBL [online] 22 December 1999 (1999-12-22), HATTORI M ET AL.: "Homo sapiens genomic DNA", XP002553831, retrieved from EBI Database accession no. AP000892 *
FRUDAKIS T ET AL: "A CLASSIFIER FOR THE SNP-BASED INFERENCE OF ANCESTRY", JOURNAL OF FORENSIC SCIENCES, vol. 48, no. 4, 1 July 2003 (2003-07-01), CALLAGHAN AND CO, CHICAGO, IL, US, pages 771 - 782, XP008040071, ISSN: 0022-1198 *
HALDER I ET AL.: "A panel of ancestry infromative markers for estimating individual biogeographical ancestry and admixture from four continents: Utility and applications", HUMAN MUTATION, vol. 29, no. 5, 2008, pages 648 - 658, XP002553830 *
HANIS C L ET AL.: "Individual admixture estimates: Disease associations and individual risk of diabetes and gallblasder disease among Mexican-Americans in Starr County, Texas", AMERICAN JOURNAL OF PHYSICAL ANTHROPOLOGY, vol. 70, 1986, pages 433 - 441, XP002553828 *
PRITCHARD JONATHAN K ET AL: "Inference of population structure using multilocus genotype data", GENETICS, GENETICS SOCIETY OF AMERICA, AUSTIN, TX, US, vol. 155, no. 2, 1 June 2000 (2000-06-01), pages 945 - 959, XP002541318, ISSN: 0016-6731 *
SCHRIVER M D ET AL.: "Ethnic-affiliation estimation by use of population-specific DNA markers", AMERICAN JOURNAL OF HUMAN GENETICS, vol. 60, 1997, pages 957 - 964, XP002553827 *
SHRIVER MARK D ET AL: "Skin pigmentation, biogeographical ancestry and admixture mapping", HUMAN GENETICS, vol. 112, no. 4, 1 April 2003 (2003-04-01), SPRINGER, BERLIN, DE, pages 387 - 399, XP002481389, ISSN: 0340-6717, [retrieved on 20030211] *

Also Published As

Publication number Publication date
JP2012050432A (ja) 2012-03-15
JP2006514553A (ja) 2006-05-11
AU2003265572A1 (en) 2004-03-03
WO2004016768A2 (en) 2004-02-26
CA2496155A1 (en) 2004-02-26
EP1578944A2 (de) 2005-09-28
AU2009225275A1 (en) 2009-10-29
WO2004016768A3 (en) 2005-12-22

Similar Documents

Publication Publication Date Title
AP2089A (en) Compositions and methods for combination antiviraltherapy
GB0411940D0 (en) Methods and compositions
EP1633718A4 (de) Zusammensetzungen und verfahren zur inhibierung von tgf-s
EP1701725A4 (de) Verfahren und zusammensetzungen
EP1545578A4 (de) Zusammensetzungen und verfahren zur behandlung von herz-kreislauf-erkrankungen
AU2003267644A8 (en) Dental compositions and methods
IL166331A0 (en) 5-arylterazole compounds compositions thereof and uses therefor
AU2003256805A8 (en) Compounds compositions and methods
AU2003287443A8 (en) Compositions and methods for pain reduction
ZA200600025B (en) Methods and compositions for interferon therapy
AU2003275268A8 (en) Hemostatic compositions and methods
AU2003212850A8 (en) Methods and compositions for treating cardiovascular disease
GB0303609D0 (en) Novel therapeutic method and compositions
IL164887A0 (en) Therapeutic 1,2,3,6-tetrahydropyrimidine-2-one compositions and methods therewith
EP1578944A4 (de) Zusammensetzungen und verfahren, um auf die abstammung zu schliessen
GB2384705B (en) Cosmetic and related compositions
EP1583557A4 (de) Vakzine-zusammensetzungen und verfahren
AU2003277025A8 (en) Ink compositions and formulation methods therefor
AU2003275240A8 (en) Methods and compositions for soluble cpg15
AU2003275069A8 (en) Compositions and methods for preventing infection
AU2003303948A8 (en) Compositions and methods for preventing infection
EP1587405A4 (de) Neue zusammensetzungen und verfahren gegen krebs
GB0327050D0 (en) Therapeutic methods compositions and uses
GB0303600D0 (en) Novel therapeutic method and compositions
GB0207224D0 (en) Tenascin-W compositions and uses thereof

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20050308

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL LT LV MK

DAX Request for extension of the european patent (deleted)
PUAK Availability of information related to the publication of the international search report

Free format text: ORIGINAL CODE: 0009015

RIC1 Information provided on ipc code assigned before grant

Ipc: C12Q 1/68 20060101ALI20051229BHEP

Ipc: G01N 33/48 20060101AFI20051229BHEP

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: DNAPRINT GENOMICS, INC.

RIC1 Information provided on ipc code assigned before grant

Ipc: G06F 19/00 20060101ALI20091110BHEP

Ipc: C12Q 1/68 20060101AFI20091110BHEP

A4 Supplementary search report drawn up and despatched

Effective date: 20091125

17Q First examination report despatched

Effective date: 20100409

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20120602